When either of these two are successful, we’ll be away.
“Anteris is committed to concluding partnership deals for TAVR development this year as outlined in its FY19 Annual Report.
Also, in 2020, Anteris aims to conclude partnership deals for supply of ADAPT® tissue.”
Ann: Anteris Operations Update, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.20 |
Change
0.200(1.67%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.20 | $11.50 | $134.6K | 11.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 520 | $12.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.20 | 191 | 3 |
View Market Depth
| Last trade - 15.17pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |